×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| ZIM Laboratories Limited | 980.85 | 40.01 | 963.3 | 0.82 | 473.0 | 30.8 |
| JENBURKT PHARMACEUTICALS LTD. | 384.75 | 65.08 | 368.93 | 14.75 | 446 | 14.2 |
| LYKA LABS LTD. | 346.24 | 27.04 | 337.98 | 0.75 | 419 | 102.0 |
ZIM Laboratories Limited, with Security Code 541400, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 92.5 | 99.2 | 100.3 | 104.4 | 67.0 | 85.2 | 95.8 | 117.3 | 82.0 | 89.7 |
| Expenses | 81.1 | 87.1 | 87.7 | 89.4 | 62.5 | 76.3 | 84.6 | 102.0 | 74.1 | 81.3 |
| Operating Profit | 11.4 | 12.1 | 12.6 | 15.1 | 4.5 | 9.0 | 11.2 | 15.4 | 7.9 | 8.4 |
| OPM % | 12.3% | 12.21% | 12.6% | 14.41% | 6.77% | 10.51% | 11.66% | 13.14% | 9.61% | 9.35% |
| Other Income | 1.9 | 1.4 | 2.4 | 0.7 | 0.6 | 1.4 | 1.1 | 1.5 | 1.0 | 1.3 |
| Interest | 1.3 | 1.4 | 1.6 | 1.3 | 1.7 | 1.2 | 1.7 | 2.3 | 2.9 | 2.9 |
| Depreciation | 4.0 | 4.0 | 3.6 | 4.6 | 3.7 | 3.7 | 3.6 | 3.9 | 4.9 | 5.0 |
| Profit before tax | 8.0 | 8.2 | 9.9 | 9.9 | -0.2 | 5.5 | 7.0 | 10.8 | 1.1 | 1.9 |
| Tax % | 29.2% | 30.7% | 33.5% | 27.9% | -35.9% | 23.3% | 31.1% | 27% | 30% | 34.3% |
| Net Profit | 5.6 | 5.7 | 6.6 | 7.1 | -0.1 | 4.2 | 4.8 | 7.9 | 0.8 | 1.2 |
| EPS in Rs | 3.47 | 3.49 | 1.35 | 1.46 | -0.03 | 0.86 | 0.99 | 1.62 | 0.16 | 0.25 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 99.4 | 101.0 | 105.4 | 67.4 | 85.8 | 96.3 | 117.9 | 81.8 | 92.1 | 96.3 |
| Expenses | 87.1 | 87.9 | 90.0 | 62.6 | 76.5 | 84.8 | 102.2 | 73.8 | 82.6 | 84.8 |
| Operating Profit | 12.3 | 13.1 | 15.5 | 4.8 | 9.3 | 11.5 | 15.6 | 8.0 | 9.5 | 11.6 |
| OPM % | 12.3% | 13% | 14.7% | 7.2% | 10.9% | 12% | 13.3% | 9.8% | 10.3% | 12% |
| Other Income | 1.4 | 2.4 | 0.7 | 1.1 | 1.4 | 1.1 | 1.5 | 1.0 | 1.3 | 1.8 |
| Interest | 1.4 | 1.6 | 1.3 | 1.7 | 1.2 | 1.7 | 2.3 | 2.9 | 2.9 | 2.7 |
| Depreciation | 4.4 | 3.9 | 4.9 | 4.0 | 4.1 | 3.9 | 3.9 | 4.9 | 5.0 | 4.9 |
| Profit before tax | 8.0 | 10.0 | 9.9 | 0.2 | 5.4 | 7.0 | 11.0 | 1.2 | 3.0 | 5.7 |
| Tax % | 31.5% | 33.9% | 27.2% | 22.2% | 23.8% | 31.8% | 26.5% | 27.2% | 19.6% | 29.9% |
| Net Profit | 5.5 | 6.6 | 7.2 | 0.2 | 4.2 | 4.8 | 8.1 | 0.9 | 2.4 | 4.0 |
| EPS in Rs | 3 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 2% |
| 3 Years: | 6% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 1% |
| 3 Years: | 23% |
| TTM: | -11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 36% |
| 3 Years: | 23% |
| 1 Year: | -14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 2% |
| 3 Years: | 6% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 2% |
| 3 Years: | 16% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 36% |
| 3 Years: | 23% |
| 1 Year: | -14% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|